Abstract There is accumulating evidence that gene expression can be regulated independently of DNA sequence changes, also called epigenetic modifications. Histone deacetylases (HDACs), a specific epigenetic group of enzymes, dynamically and reversibly removes acetyl groups from histone tails projecting from the nucleosome. Clinically, valproic acid fetopathy sheds some insight into the effects of altered HDACs on human embryonic development, since valproic acid is an antiepileptic drug and an HDAC inhibitor. The fetal anomalies include severe renal dysgenesis, supporting the role played by HDACs in human kidney development. Our recent studies have shown that HDACs regulate the transcriptional networks required for controlling the cell cycle, Wnt signaling, and the pathway upstream of the GDNF/RET signaling pathway in the developing kidney. Here, we describe novel HDAC target genes not previously implicated in renal development based on studies using genome-wide microarrays. These genes can be divided into transcription factors, modulators of matrix biology, chromatin remodelers, and DNA repair genes. We also report that HDACs are requisite for tissue-specific gene expression.
Introduction
Chromatin modifications occurring independently of DNA sequence changes introduce another layer of understanding of cell function, regulation, and identity. Acetylation, methylation, phosphorylation, and ubiquitination are all epigenetic modifications that occur on specific residues of histone tails, lead to alterations in the coiling of DNA, and affect proteinprotein interactions [1, 2] . These epigenetic combinations generate a "histone code," which research increasingly demonstrates is vital for regulation of gene expression. Histone acetylation is a dynamic and reversible alteration on histone tails mediated by histone acetyltransferases (HATs) and histone deacetylases (HDACs). HDACs are a conserved group of enzymes that remove acetyl groups from histone tails that project from the nucleosome, causing condensed chromatin architecture. Initially, HDACs were described as forming heterochromatin and repressors of gene expression. This generalization has been modified after studies have recently shown activation of various genes [3, 4] . HDACs are divided into four classes based on sequence homology to yeast HDAC genes: Class I (HDAC 1-3, and 8), Class II (HDAC 4-7, 9, and 10), Class III (Sir2/SIRT 1-7), and Class IV (11) [4] . Studies show evidence of elevated HDAC activity in propagating cells, with dysregulation of HDACs implicated in causing cancer, cardiovascular, and immune disorders [5] . The role of HDACs in embryogenesis and organogenesis, however, is just beginning to be explored. Studies thus far have supported individual roles for specific HDACs. For example, HDAC 1 is imperative for regulating cell proliferation and is essential for embryo survival [6] . Also, HDAC 1 and 2 perform redundant yet vital functions in cardiac growth and development and in the differentiation of oligodendrocytes [7, 8] . HDAC 4, 5, and 9 exhibit antihypertrophic properties in chondrocytes and the heart, and HDAC 7 null mice have loss of vascular integrity, causing lethality by E11.0 [9] [10] [11] .
Normal metanephric kidney development in vertebrates begins with the differentiation of the metanephric mesen-chyme (MM), from the caudal portion of the intermediate mesoderm. Then, reciprocal inductive interactions occur between the MM and the adjacent ureteric bud (UB), an outgrowth from the medial mesonephric (or Wolffian) duct resulting in formation of the collecting duct system, the calyces, the ureter, and functional nephrons [12, 13] . Recent work from our laboratory demonstrated that HDACs are involved in several signaling pathways that are vital for normal metanephric kidney development (Chen and El-Dahr, unpublished data). These include the Wntcatenin pathway, the phosphatidylinositol 3-kinase (PI3K)/ Although it has not been established that genetic mutations in HDAC genes cause abnormal embryogenesis in humans, there is evidence that HDAC genes are required in human embryonic development. Valproic acid, an antiepileptic drug with properties of Class I and Class II HDAC inhibition, is associated with congenital anomalies after first-trimester fetal exposure [14] . These malformations include extensive kidney abnormalities and sequelae, which will be discussed as a case report, and suggest the function of HDACs in human kidney development.
To reconstruct this model, we examined the role of HDACs in metanephric kidney development through the use of a pharmacological HDACi. Scriptaid, belonging to the hydroxamic acid class of HDACi, inhibits Class I and II HDACs [15] . Nullscript, used as the control, is a structural analog of Scriptaid, with no HDACi ability [16] . Day 13.5 embryonic kidneys were cultured with either Scriptaid or Nullscript for 6 h and a genome-wide microarray analysis was performed from extracted RNA followed by Ingenuity Pathway software analysis (IPA). The results revealed that HDACs regulate the major transcriptional networks known to regulate renal development (Chen and El-Dahr, unpublished data). However, a great number of significantly affected genes have no known function in kidney development. The aim here is to recognize and discuss common themes of the functions of these novel genes to help decipher the role of HDACs.
Materials and methods

Genome-wide microarray experiment
Microarray analysis was performed according to established protocols [17] . Total RNA was extracted in three independent experiments from CD1 mouse kidney explants treated Nullscript-treated kidneys was mixed with the same amount of reverse color cyanine from the oppositely treated kidney samples. The cDNA was hybridized to Agilent 44 K Whole Mouse Genome Oligonucleotide Microarray (containing 41,000 probes), the arrays were scanned using a dual-laser DNA microarray scanner (Agilent), data were extracted from images by Feature Extraction software 6.1 (Agilent), and network analysis was accomplished through IPA software. The data were RMA-normalized followed by dye-swap correction for the experiments and filtering by statistical significance (t test, p value=0.05, using multiple test correction -the Benjamini and Hochberg false discovery rate). We report here the top 20 upregulated and top 20 downregulated genes with the most significant changes and that, to our knowledge, have not been previously reported to be involved in regulation of kidney development.
Ex vivo metanephric organ culture Ex vivo culture protocol was performed as previously described [18] .
IPA and data analysis
Novel genes are selected from the significantly upregulated and downregulated transcripts (change≥1.5 -fold; p<0.05; n=3 independent experiments). The top 250 transcripts are further selected based upon known function and expression patterns. Of these, genes are further designated if they have similar gene function.
Case report
A 6-year-old girl presented with altered mental status. She had had episodes of screaming, irritability, head banging, hair pulling, and biting over the past week. Her past medical history was significant for valproic acid fetopathy, patent ductus arteriosus, atrial septal defect, dilation of the third and lateral brain ventricles, hypertension, gastro-esophageal reflux, swallowing dysfunction, and developmental delay. The patient had facial dysmorphism with puffiness. Her physical examination was otherwise negative. Pertinent laboratory values included a BUN 126, creatinine of 6.6, and a potassium level of 6.3. Urinalysis had a specific gravity of 1.011, pH of 7.5, with 4+ protein, large hemoglobin, 50-100 red blood cells, and 10-20 white blood cells. Kidney ultrasound demonstrated the presence of hypoplastic kidneys (right length 3.1 cm, left length 3.0 cm) with increased parenchymal echogenicity and mild hydronephrosis. Voiding cystogram showed the presence of grade III vesicoureteral reflux (VUR) in the right and of grade II VUR in the left kidney. She was treated with hemodialysis with a slow return to baseline AKT pathway, and the TGF-β signaling pathway. All three signaling cascades display significant dysregulation with histone deacetylase inhibitor (HDACi) treatment, thereby revealing the essential function of HDACs.
with Scriptaid (2 μg/ml) or Nullscript (2 μg/ml) for 6 h. Cyanine-labeled cDNA from both the Scriptaid-and mentation. A diagnosis of end-stage renal disease was established secondary to renal dysplasia from gestational valproic acid use. As noted earlier, valproic acid is a Class I and II HDAC inhibitor.
Results
In a recent study using genome-wide microarray analysis results, our laboratory found that~4,800 of 41,000 (~12%) probes were significantly altered from HDACi treatment by ≥1.5-fold (p≤0.05, n=3) with 5% of gene transcripts upregulated (range 1.5-to 14-fold increase, n=2,085) and 7% of gene transcripts downregulated (range 1.5-to 26-fold decrease, n=2,865) (Chen and El-Dahr, unpublished data). Furthermore, we reported that the networks controlling the GDNF/RET signaling pathway are significantly altered by HDACi treatment. In addition, IPA network analysis identified other renal developmental pathways where numerous genes were dysregulated with HDAC inhibition. clearer as we realized that multiple genes with similar functions were being turned either off or on. Using that information, we are able to postulate conclusions about innate functions of HDACs.
Discussion
Major findings discovered by IPA network analysis include several signaling cascades with numerous altered genes following HDAC treatment that are recognized to be intimately involved in renal morphogenesis. The Wnt/β-catenin pathway is fundamental in nephrogenesis as well as UB outgrowth and branching [19, 20] . The PI3K/AKT signaling pathway is downstream from the GDNF/RET pathway and mediates localized cell proliferation and directed cell movement in the prospective UB tip [21] . The TGF-β pathway delays branching while permitting elongation in UB development. This function was determined because kidneys cultured with TGF-β led to an unusual anomaly of branching, where the UB elongated without branching until reaching the periphery of the kidney [22] .
By evaluating these three pathways, it is apparent that HDAC inhibition causes severe dysregulation. As stated above, the genes colored green have significantly decreasedfold expression, while the red genes have significantly increased expression. In the Wnt-catenin network, Wnt family members 2, 4, and 5 and Frizzled receptors have decreased expression. Continuing downstream, nuclear LEF/TCF is repressed with the downstream effectors Myc, Ccnd1, Gja1, and Axin2 all having significantly decreased expression. SFRP1, a known Wnt inhibitor, has increased expression, also contributing to the severe repression of this pathway.
The PI3K/AKT pathway reveals downregulation of the P110 subunit of PI3K with downstream decreased expression of AKT. The effectors further downstream also display repression, as can be seen with CCd1, P53, and Bcl-2. The TGF-β network continues to show repression beginning with the BMP family to its receptor. Then, the Smad family downstream exhibits consistent downregulation. Although GCS and PITX2 show increased expression, it is likely due to secondary factors since the pathway is repressed until that point. In summary, close assessment of these key renal developmental pathways reveal that they are significantly repressed following HDAC inhibition by direct inhibition of genes in these pathways or by secondary effects.
Other novel genes that are not part of a known nephric embryonic network also show decreased expression after HDACi treatment. These genes can be grouped into the following functional classes: transcription factors, chromatin remodelers, genes that control the extracellular matrix, and DNA repair genes (Tables 1, 2):
Transcription factors: A variety of transcription factors
have decreased expression after HDAC inhibition. Among them are Pre-B cell leukemia transcription factor 1 (Pbx1), transcription factor AP4 (Tcfap4), E74-like factor 5 (Elf5), SRY-box containing gene 7 (Sox7), basic helix-loop-helix family member e22 (Bhlhb5), myelocytomatosis oncogene (Myc), and zinc finger protein X-linked (Zfx), which all regulate when genes are turned on and off. Pbx1, Tcfap4, and Elf5 function as transcriptional activators. Sox7, Bhlhb5, Myc, and Zfx determine cell fate. Also, general transcription factor II I (Gft2i) functions in cell proliferation. The cell cycle regulator cyclin D1 (Ccnd1) is vital for G1/S progression. Inhibition of the transition through the G1 to S phase of the cell cycle forces cells to become quiescent and enter the G o phase. Collectively, the function of all these inhibited genes strongly suggests that decreased proliferation is a major mechanism mediating the negative effects of HDACi on renal growth. 2. Chromatin modifiers/remodelers: Genes such as malespecific lethal 1 homolog (Msl1), SET domain containing 1B (Set1b), chromodomain helicase DNA binding protein 3 (Chd3), male-specific lethal 2-like 2 (Msl3l2), protein arginine N-methyltransferase 1 (Prmt1), forkhead A1 (Foxa1), DNA methyltransferase 3a (Dnmt3a), and sirtuin 1 (Sirt1) are all chromatin remodelers and their expression is decreased in response to HDACi. Msl1 is a part of a HAT complex. Set1b and Prmt1 are both histone methyltransferases, known to add a methyl group to histone tails and cause repression. Foxa1 is a pioneer factor acting by opening chromatic architecture, forming euchromatin, and allowing protein interactions with DNA [23] . Dnmt3a is a DNA methyltransferase that mediates de novo DNA methylation, and is a key developmental regulator. Sirt1 is a class III HDAC that acts in a complex to recruit HDAC enzymes leading to transcriptional repression and also deacetylates the tumor suppressor p53. It is interesting to note that while HDAC inhibition is an identified chromatin remodeler itself, it appears to have wide-ranging effects on other epigenetic modifiers.
3. Genes controlling the extracellular matrix: The cellular environment is altered by decreased synthesis of genes important for generating and maintaining the extracellular matrix. Scleraxis (Scx), a regulator of type I collagen, showed a −5.4-fold decrease in expression with HDACi treatment. Also, matrix metallopeptidase 14 (Mmp14) showed a −4.5-fold decrease in expression. Mmp14 functions to break down the extracellular matrix in embryonic development. In the kidney, it may be necessary to clear the extracellular environment to allow branching morphogenesis to occur. Versican (Vcan or Cspg2) encodes a chondroitin sulfate proteoglycan, a major extracellular component known to be involved in cell-to-cell interactions, proliferation, and tissue morphogenesis and maintenance. Having decreased expression of all these genes can be interpreted to have a deleterious effect on the developing renal system. 4. DNA repair genes: DNA repair mechanisms also appear to be inhibited with HDACi treatment. Nibrin (Nbn) is a factor in the MRE11/RAD50/NBN (MRN Renal medulla and ureteric trunk A transcription factor that acts as a "pioneer" factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones Dnmt3a −2.7, −2.9 N/A This gene encodes a DNA methyltransferase that functions in de novo methylation. Homozygotes for a targeted null mutation become runted and die around 4 weeks of age Sirt1 −1.5 N/A NAD-dependent protein (histone) deacetylase, which regulates processes such as apoptosis and muscle differentiation by deacetylating key proteins, e.g., p53
Expression pattern information was found in www.gudmap.org and relevant literature. Gene function was found in www.genecards.org and relevant literature CM: condensing mesenchyme; UB: ureteric bud complex) with decreased expression of -3.5-fold. It is vital in the double-stranded DNA break repair pathway, in the maintenance of telomere activity, cell cycle checkpoint regulation, and meiosis. Nucleoside diphosphate-linked moiety-type motif 15 (Nudt15) binds to and helps prevent breakdown of proliferating nuclear cell antigen (PNCA). PNCA functions in DNA replication and in DNA repair through the RAD6-dependent pathway. When DNA repair mechanisms are disrupted, DNA mutations accumulate and force the cell to undergo cell death.
When investigating the genes with upregulated expression, many genes that are induced are not normally expressed in the developing kidney. These genes are known to have expression in a variety of organ systems, including the gonadal system, the nervous system, and the musculoskeletal system. Desert hedgehog (Dhh), extraembryonic spermatogenesis homeobox 1 (Esx1), fibronectin type 3 and ankyrin repeat domains 1 (Fank1), heat shock protein 2 (Hspa2), Ly6/Plaur domain containing 3 (Lypd3), transcription factor-like 5 (TCFl5), and pre-B cell leukemia homeobox 4 (Pbx4) function in early spermatogenesis and testis development. None of them has ever been described as having expression in the developing kidney, but they do have de novo expression with HDACi treatment. Likewise, Rho family GTPase 1 (Rnd1), homeobox A1 (Hoxa1), neuronal PAS domain protein 1 (Npas1), zinc finger, CCHC domain-containing 12 (Zcchc12), forkhead box 6 (Foxo6), LIM homeobox protein 5 (Lhx5), NK6 homeobox 2 (Nkx6-2), oligodendrocyte transcription factor 1 (Olig1), deltex 1 homolog (Dtx1), synapsin II (Syn2), and serine peptidase inhibitor, clade I, member 1 (Serpini1) play a role in brain differentiation, neuronal, and central nervous system cellular growth. Bone morphogenetic protein subunits a and b (Bmp8a and Bmp8b), FBJ osteosarcoma oncogene (Fos), and osteopetrosisassociated transmembrane protein 1 (Ostm1) are factors involved in bone formation, skeleton maintenance, and osteoclastic maturation. It can be deduced that HDACs function to keep the chromatin compact, thus maintaining tissue-specific gene expression. This de novo expression impairs differentiation and can alter development since the tissues are dysregulated.
Metanephric kidney culture experiments performed in our laboratory have demonstrated that HDACi treatment not only affects the key transcriptional networks of kidney development, but also results in renal hypoplasia due to decreased UB branching and impaired nephrogenesis (Chen and El-Dahr, unpublished data). HDACi treatment alters various gene pathways and it is likely that the combined effect of these mechanisms involves global kidney development.
When evaluating the functions of genes whose expression is dysregulated significantly, there is a clear connection that these impaired genes play a role in growth and proliferation. These manifestations are consistent with what was demonstrated in our patient with valproic acid fetopathy. Also, recent evidence investigating the developmental pathways effected with gestational valproic acid exposure demonstrate that the same developmental pathways are dysregulated [24] , as with our study with Scriptaid, confirming that valproic acid fetopathy is very likely due to HDAC inhibition.
